Amazon has been eyeing the $400 billion U.S. prescription drug market for well over a year, but it's coming at it in a different way than people thought. While Amazon originally wanted to sell pharmaceutical drugs through its Amazon Business marketplace, the company ended up abandoning those plans earlier this year.